Abstract
Chromatin structure is regulated through posttranslational modifications of histone variants that modulate transcription. Although highly homologous, histone variants display unique amino acid sequences associated with specific functions. Abnormal incorporation of histone variants contributes to cancer initiation, therapy resistance, and metastasis. This study reports that, among its biologic functions, histone H3.1 serves as a chromatin redox sensor that is engaged by mitochondrial H2O2. In breast cancer cells, the oxidation of H3.1Cys96 promotes its eviction and replacement by H3.3 in specific promoters. We also report that this process facilitates the opening of silenced chromatin domains and transcriptional activation of epithelial-to-mesenchymal genes associated with cell plasticity. Scavenging nuclear H2O2 or amino acid substitution of H3.1(C96S) suppresses plasticity, restores sensitivity to chemotherapy, and induces remission of metastatic lesions. Hence, it appears that increased levels of H2O2 produced by mitochondria of breast cancer cells directly promote redox-regulated H3.1-dependent chromatin remodeling involved in chemoresistance and metastasis.
Original language | English (US) |
---|---|
Article number | 113897 |
Journal | Cell reports |
Volume | 43 |
Issue number | 3 |
DOIs | |
State | Published - Mar 26 2024 |
Funding
This project was supported by National Cancer Institute grants R01CA216882 (to M.G.B.), U54268084 and U54261694 (to V.B.), R01CA225002 (to V.B.); National Institute of Environmental Health Sciences grants R01ES035723 and R01ES028149 (both to M.G.B.); National Institute of Allergy and Infectious Diseases grant R01AI131267 (to M.G.B.); National Heart, Lung and Blood Institute grants R01HL163820 (to M.G.B.) and P01HL149620 (to S.R.); and National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK134064 (to S.R.). We are also grateful for the financial support from the Lefkofsky Foundation Innovator Award (to M.G.B. and V.B.). We are also grateful to Northwestern University Center for Advanced Microscopy (CAM), Quantitative Data Sciences Core (QDSC) and NUSeq for technical assistance. Conceptualization: F.R.P. B.N.G. S.R. V.B. and M.G.B. Investigation: F.R.P. D.R.C. K.P. M.J.S. F.T.O. Y.H. J.M.D. A.M. and M.G.B. Formal analysis: F.R.P. D.R.C. and K.P. Methodology: F.R.P. C.M.F. D.R.S. A.P.G. B.N.G. S.R. V.B. and M.G.B. Visualization: F.R.P. and K.P. Writing: F.R.P. D.R.S. A.P.G. B.N.G. and M.G.B. The authors declare no competing interests. This project was supported by National Cancer Institute grants R01CA216882 (to M.G.B.), R01CA228272 (to V.B.), R01CA225002 (to V.B.), and P30CA060553 (to V.B.); National Institute of Environmental Health Sciences grants R01ES035723 and R01ES028149 (both to M.G.B.); National Institute of Allergy and Infectious Diseases grant R01AI131267 (to M.G.B.); National Heart, Lung and Blood Institute grants R01HL163820 (to M.G.B.) and P01HL149620 (to S.R.); and National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK134064 (to S.R.). We are also grateful for the financial support from the Lefkofsky Foundation Innovator Award (to M.G.B. and V.B.).
Keywords
- CP: Cancer
- EMT
- H3
- ROS
- breast cancer
- chemoresistance
- drug resistance
- histone variants
- metastasis
- redox
- thiol oxidation
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology